AI assistant
ORAGENICS INC — Director's Dealing 2016
Feb 17, 2016
35380_dirs_2016-02-17_5de0d819-8661-4df4-95f7-4975b02c334f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORAGENICS INC (OGEN)
CIK: 0001174940
Period of Report: 2016-02-16
Reporting Person: POPE CHARLES L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-02-16 | Common Stock | A | 40000 | $0.00 | Acquired | 201063 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-02-16 | Non-Employee Director Option (Right to Buy) | $0.84 | A | 80000 | Acquired | 2026-02-16 | Common Stock (80000) | Direct |
Footnotes
F1: Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests equally over each of the four calendar quarters during 2016.
F2: Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest equally over two years commencing on the first anniversary of the grant date. The option exercise price is the closing price on the date of the grant, February 16, 2016.